24.09.22 (ÀÏ) 05:02

Dailypharm

X
"ó¹æÇàÅ Å뺸·Ð ÇÑ°è"..½Ç¸í°ø°³ ½Åȣź
±èÅÂÇü ±âÀÚ 2005-04-27 13:24:53
"ó¹æÇàÅ Å뺸·Ð ÇÑ°è"..½Ç¸í°ø°³ ½Åȣź
±èÅÂÇü ±âÀÚ 2005-04-27 13:24:53
[DPÅäÇÈ] ÁÖ»çó¹æ »óÀ§ 25% 5¿ù °øÇ¥..."75%´Â °úÀ×Àΰ¡" ºÒ¸¸



|´º½ººÐ¼®=½ÉÆò¿ø ÀÇ·á±â°ü ÁÖ»çÁ¦ ó¹æ·ü °ø°³|

°Ç°­º¸Çè½É»çÆò°¡¿øÀÌ 26ÀÏ Áß¾ÓÆò°¡À§¿øȸ¸¦ ¿­¾î ÁÖ»çó¹æÀÌ ¾çÈ£ÇÑ º´ÀÇ¿ø ¸í´ÜÀ» °ø°³Å°·Î °áÁ¤ÇÑ °ÍÀº 4³â°£ ½Ç½ÃÇØ¿Â ¾àÁ¦ ÀûÁ¤¼º Æò°¡°á°ú¸¦ Àû±Ø È°¿ëÇÏ°Ú´Ù´Â ¶æÀ¸·Î Çؼ®µÈ´Ù.

±âÁ¸ Æò°¡°á°ú¸¦ ÀÇ·á±â°ü¿¡ Å뺸¸¸ ÇÏ´Â ¼Ò±ØÀûÀÎ ¹æ¹ýÀÌ ¾Æ´Ï¶ó º´ÀÇ¿øÀÇ ½Ç¸íÀ» °ø°³ÇÏ´Â Àû±Ø¼ºÀ» ¶ì°Ú´Ù´Â °ÍÀÌ´Ù.

½ÉÆò¿øÀº Áß¾ÓÆò°¡À§¿øȸ°¡ ¸í´Ü°ø°³¸¦ °áÁ¤ÇÔ¿¡ µû¶ó ÀÇ¿ø 5,098°÷°ú º´¿ø 260°÷(2004³â 4/4ºÐ±â)ÀÇ ½Ç¸íÀ» ³»´Þ °øÇ¥ÇÑ´Ù´Â ³»ºÎ ¹æħÀ» ¼¼¿î °ÍÀ¸·Î ÀüÇØÁ³´Ù.

"ÁÖ»çó¹æ·ü °ø°³´Â ±¹¹Î ¼±ÅÃ±Ç È®´ë"

½ÉÆò¿ø °ü°èÀÚ´Â ÀÌ¿Í °ü·Ã ¡°Ã³¹æ·ü °ø°³¹æ½ÄÀ» µÑ·¯½Î°í ³í¶õÀÌ ¸¹¾ÒÁö¸¸ ó¹æ·üÀÌ ¾çÈ£ÇÑ °÷ºÎÅÍ °ø°³ÇÏ´Â Æ÷ÁöƼºê ¹æ½ÄÀ» äÅÃÇß´Ù¡±¸é¼­ ¡°ÀÇ·á°è°¡ ¿ì·ÁÇÏ´Â ºñ³­À̳ª ȯÀÚ Áø·áÀÇ Â÷ÁúÀº ¿ì·ÁµÇÁö ¾ÊÀ» °Í¡±À̶ó°í ¸»Çß´Ù.

½ÉÆò¿øÀÇ ¶Ç ´Ù¸¥ °ü°èÀÚ´Â ¡°ÁÖ»çÁ¦ ó¹æ·üÀÌ ³·°í ³ôÀº ÀÇ·á±â°üÀ» ¼±ÅÃÇÏ´Â ¹®Á¦´Â °á±¹ ¼ÒºñÀÚµéÀÌ ÆÇ´ÜÇØ¾ß ÇÒ ¹®Á¦¡±¶ó°í °­Á¶Çß´Ù.

»ç½Ç Áß¾ÓÆò°¡À§´Â ÀÇ·á±â°ü ¸í´Ü°ø°³¸¦ µÑ·¯½Î°í ÀÇ·á°è ´ëÇ¥¿Í ¼ÒºñÀÚ ´Üü°£ °ø¹æÀ» ¹úÀÎ °ÍÀ¸·Î ÀüÇØÁ³´Ù.

¸í´Ü°ø°³¸¦ ÃÖ¼ÒÈ­ÇÏ·Á´Â ÀÇ·á°èÀÇ ÁÖÀå¿¡ ½Ã¹Î´ÜüµéÀº ÁÖ»çÁ¦ ó¹æ·üÀÌ ³ôÀº ÀÇ·á±â°üÀ» °ø°³ÇØ¾ß ÇÑ´Ù´Â ÀÔÀåÀ¸·Î ¸Â¼± °ÍÀÌ´Ù.

ÀÇ»çÇùȸ ¹ÚÈ¿±æ ºÎȸÀåÀº ¡°½ÇÁ¦ Áֻ縦 ¸¹ÀÌ ¾²°í Àû°Ô ¾²´Â °Í¿¡ ´ëÇÑ Æò°¡±âÁØÀÌ ¸íÈ®ÇÏÁö ¾Ê´Ù¡±¸é¼­ ¡°ÁÖ»çÁ¦ ó¹æ±âÁØÀº °¢ ³ª¶óÀÇ È¯°æ°ú ¹®È­¿¡ µû¶ó Á¤ÇØÁ®¾ß ÇÑ´Ù¡±°í ÁÖÀåÇß´Ù.

"¼öÄ¡ÅëÇÑ ÀÏ·üÀûÀÎ °ø°³¿£ ¹Ý´ë"

¹Ú ºÎȸÀåÀº ÀÌ¾î ¡°ÀÏ·üÀûÀÎ ¼öÄ¡¸¦ °ø°³ÇÏ´Â °Í¿¡´Â ¹Ý´ëÇÑ´Ù¡±¸ç ¸í´Ü°ø°³ °áÁ¤¿¡ ºÒ¸¸À» Ç¥ÃâÇß´Ù.

ÀÇ·á°è´Â ¶ÇÇÑ Ã³¹æ·üÀÌ ¾çÈ£ÇÑ ÀÇ·á±â°üÀÇ ¸í´ÜÀ» °ø°³ÇÏ´Â Æ÷ÁöƼºê ¹æ½ÄÀ» ÃëÇÏ´õ¶óµµ °á±¹ ¸í´Ü¿¡ ºüÁø 75%´Â ÁÖ»çÁ¦¸¦ °úÀ×ó¹æÇÏ´Â °ÍÀ¸·Î ¿ÀÀÎÇÑ´Ù¸ç °á±¹ ÀÇ·á±â°ü¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ̶ó°í ÁÖÀåÇØ¿Ô´Ù.

ÇÏÁö¸¸ ½Ã¹Î´Üü¿Í ½ÉÆò¿øÀÇ ÀÔÀåÀº ÀÌ¿Í ´Ù¸£´Ù.

¼Ò½Ã¸ðÀÇ ±èÀÚÇý »ç¹«ÃÑÀåÀº ¡°½Ç¸í¸¦ °ø°³ÇØ¾ß ÇÑ´Ù´Â ¿øÄ¢¿¡´Â ÀÌ¹Ì ÇÕÀÇÇß´Ù¡±¸é¼­ ¡°¹®Á¦´Â ¸í´ÜÀ» °ø°³ÇÑ´Ù°í Çؼ­ ÁÖ»çÁ¦ ó¹æ °¨¼ÒÈ¿°ú¸¦ °ÅµÑ °ÍÀ̶ó°í »ý°¢ÇÏÁö ¾Ê´Â´Ù¡±°í ÀüÁ¦Çß´Ù.

±è »ç¹«ÃÑÀåÀº µû¶ó¼­ ¡°¸í´Ü °ø°³ÀÌÈÄ¿¡ ÀÇÇù ÀÚüÀûÀ¸·Î ÀÚÀ²ÀûÀÎ ³ë·ÂÀÌ º´ÇàµÅ¾ß ÇÑ´Ù¡±¸é¼­ ¡°½Ã¹Î´Üüµéµµ Áö¼ÓÀûÀÎ Ä·ÆäÀÎÀ» ¹ú¿© ³ª°¡°Ú´Ù¡±°í µ¡ºÙ¿´´Ù.

½ÉÆò¿ø °ü°èÀÚ´Â ¡°È¯ÀÚÀÇ ±¸¼º, Áø·á°ú µîÀ» °¨¾ÈÇ߱⠶§¹®¿¡ ÀÚ·á¿¡ ´ëÇÑ ½Å·Ú¼ºÀº ÀÌ¹Ì È®º¸µÈ »óÅ¡±¶ó°í ÀüÁ¦ÇÑ µÚ ¡°ÀÇ»çµéÀÇ ÁÖ»çó¹æ·üÀÌ ÁÙÁö ¾ÊÀ» °æ¿ì¿¡´Â Æ÷ÁöƼºê ¹æ½ÄÀÌ °í·ÁµÉ °Í¡±À̶ó°í ¿¹»óÇß´Ù.

À̹ø ÁÖ»çó¹æ °ø°³´Â ÀÚ·áÀÇ ½Å·Úµµ µîÀ» ¹®Á¦»ï¾Ò´ø ÀÇ·á°èÀÇ ¹Ý´ë ³í¸®¸¦ ÀÇ·á¼ÒºñÀÚÀÇ ¾Ë±Ç¸® ¶ó´Â ´ëÀǸíºÐÀÌ ¿ì¼±ÇÑ´Ù´Â »ç½ÇÀ» º¸¿©Áá´Ù.

CT, Á¦¿ÕÀý°³µî ½Ç¸í°ø°³ ¸íºÐ È®º¸

µû¶ó¼­ ½É»çÆò°¡¿øÀº À̹ø °áÁ¤À¸·Î ÀÎÇØ ÇöÀç ÁøÇàÁßÀÎ Àç¿ÕÀý°³, CT, Ç×»ýÁ¦, °í°¡¾à, ºÎ½ÅÇÇÁúÈ£¸£¸óÁ¦ µî ÀϺΠÆò°¡Ç׸ñÀÇ °æ¿ì ÀÚ·áÀÇ °´°ü¼º¸¸ È®º¸µÈ´Ù¸é ¾ðÁ¦µçÁö °ø°³ÇÒ ¼ö ÀÖ´Â ¸íºÐÀ» È®º¸ÇÑ ¼ÀÀÌ´Ù.

°á±¹ ÁÖ»çó¹æ °ø°³´Â ÀûÁ¤Áø·á¸¦ À¯µµÇϱâ À§ÇÑ Æò°¡¹æ¹ý °¡¿îµ¥ ¡®½Ç¸í°ø°³¡¯¸¦ ¾Ë¸®´Â ½ÅȣźÀÎ °ÍÀÌ´Ù.

¿ä¾ç±Þ¿© ÀûÁ¤¼ºÆò°¡°¡ ¼Ò±ØÀû Å뺸¹æ½Ä¿¡¼­ ½Ç¸í°ø°³¶ó´Â ¡°Ë´Ù¸®¸¦ °ÅÃÄ Áø·áºñ¸¦ °¡°¨Áö±ÞÇÏ´Â ¹æ¾Èµµ ÃßÁøÇÒ °ÍÀÎÁö ÇâÈÄ ±ÍÃß°¡ ÁÖ¸ñµÈ´Ù.
±èÅÂÇü ±âÀÚ (thkim@dailypharm.com) ±âÀÚÀÇ ´Ù¸¥±â»ç º¸±â
  • Àμâ
  • Ä«Ä«¿ÀÅå
  • ÆäÀ̽ººÏ
  • Æ®À§ÅÍ
  • 1
/home/dailypharm/issueData2017/
µ¶ÀÚÀÇ°ß
1
À͸íÀÇ°ß ¾²±â | ½Ç¸íÀÇ°ß¾²±â ¿î¿µ±ÔÄ¢
´Ý±â

´ñ±Û ¿î¿µ¹æ½ÄÀº

´ñ±ÛÀº ½Ç¸í°ÔÀç¿Í À͸í°ÔÀç ¹æ½ÄÀÌ ÀÖÀ¸¸ç, ½Ç¸íÀº À̸§°ú ¾ÆÀ̵𰡠³ëÃâµË´Ï´Ù. À͸íÀº ÇʸíÀ¸·Î µî·Ï °¡´ÉÇϸç, ´ë´ñ±ÛÀº À͸íÀ¸·Î µî·Ï °¡´ÉÇÕ´Ï´Ù.

´ñ±Û ³ëÃâ¹æ½ÄÀº

»õ·Î¿î ´ñ±ÛÀ» ¿Ã¸®´Â ÀϹÝȸ¿øÀº ´ñ±ÛÀÇ ÇÏ´Ü¿¡ ½Ç½Ã°£ ³ëÃâµË´Ï´Ù.

´ñ±ÛÀÇ »èÁ¦ ±âÁØÀº

´ÙÀ½ÀÇ °æ¿ì »çÀü Å뺸¾øÀÌ »èÁ¦ÇÏ°í ¾ÆÀ̵ð ÀÌ¿ëÁ¤Áö ¶Ç´Â ¿µ±¸ °¡ÀÔÁ¦ÇÑÀÌ µÉ ¼öµµ ÀÖ½À´Ï´Ù.

  • ÀúÀ۱ǡ¤ÀÎ°Ý±Ç µî ŸÀÎÀÇ ±Ç¸®¸¦ ħÇØÇÏ´Â °æ¿ì

    »ó¿ë ÇÁ·Î±×·¥ÀÇ µî·Ï°ú °ÔÀç, ¹èÆ÷¸¦ ¾È³»ÇÏ´Â °Ô½Ã¹°

    ŸÀÎ ¶Ç´Â Á¦3ÀÚÀÇ ÀúÀÛ±Ç ¹× ±âŸ ±Ç¸®¸¦ ħÇØÇÑ ³»¿ëÀ» ´ãÀº °Ô½Ã¹°

  • ±Ù°Å ¾ø´Â ºñ¹æ¡¤¸í¿¹¸¦ ÈѼÕÇÏ´Â °Ô½Ã¹°

    ƯÁ¤ ÀÌ¿ëÀÚ ¹× °³Àο¡ ´ëÇÑ ÀνŠ°ø°ÝÀûÀÎ ³»¿ëÀÇ ±Û ¹× Á÷Á¢ÀûÀÎ ¿å¼³ÀÌ »ç¿ëµÈ °æ¿ì

    ƯÁ¤ Áö¿ª ¹× Á¾±³°£ÀÇ °¨Á¤´ë¸³À» Á¶ÀåÇÏ´Â ³»¿ë

    »ç½Ç È®ÀÎÀÌ ¾ÈµÈ ¼Ò¹®À» À¯Æ÷ ½ÃÅ°´Â °æ¿ì

    ¿å¼³°ú ºñ¾î, ¼Ó¾î¸¦ ´ãÀº ³»¿ë

    Á¤´ç¹ý ¹× °øÁ÷¼±°Å¹ý, °ü°è ¹ý·É¿¡ ÀúÃ˵Ǵ °æ¿ì(¼±°üÀ§ ¿äû ½Ã Áï½Ã »èÁ¦)

    ƯÁ¤ Áö¿ªÀ̳ª ´Üü¸¦ ºñÇÏÇÏ´Â °æ¿ì

    ƯÁ¤ÀÎÀÇ ¸í¿¹¸¦ ÈѼÕÇÏ¿© ÇØ´çÀÎÀÌ »èÁ¦¸¦ ¿äûÇÏ´Â °æ¿ì

    ƯÁ¤ÀÎÀÇ °³ÀÎÁ¤º¸(Áֹεî·Ï¹øÈ£, ÀüÈ­, »ó¼¼ÁÖ¼Ò µî)¸¦ ¹«´ÜÀ¸·Î °Ô½ÃÇÏ´Â °æ¿ì

    ŸÀÎÀÇ ID ȤÀº ´Ð³×ÀÓÀ» µµ¿ëÇÏ´Â °æ¿ì

  • °Ô½ÃÆÇ Æ¯¼º»ó Á¦ÇѵǴ ³»¿ë

    ¼­ºñ½º ÁÖÁ¦¿Í ¸ÂÁö ¾Ê´Â ³»¿ëÀÇ ±ÛÀ» °ÔÀçÇÑ °æ¿ì

    µ¿ÀÏ ³»¿ëÀÇ ¿¬¼Ó °ÔÀç ¹× ¿©·¯ ±â»ç¿¡ Áߺ¹ °ÔÀçÇÑ °æ¿ì

    ºÎºÐÀûÀ¸·Î º¯°æÇÏ¿© ¹Ýº¹ °ÔÀçÇÏ´Â °æ¿ìµµ Æ÷ÇÔ

    Á¦¸ñ°ú °ü·Ã ¾ø´Â ³»¿ëÀÇ °Ô½Ã¹°, Á¦¸ñ°ú º»¹®ÀÌ ¹«°üÇÑ °æ¿ì

    µ·¹ú±â ¹× Á÷¡¤°£Á¢ »ó¾÷Àû ¸ñÀûÀÇ ³»¿ëÀÌ Æ÷ÇÔµÈ °Ô½Ã¹°

    °Ô½Ã¹° Àбâ À¯µµ µîÀ» À§ÇØ ³»¿ë°ú ¹«°üÇÑ Á¦¸ñÀ» »ç¿ëÇÑ °æ¿ì

  • ¼ö»ç±â°ü µîÀÇ °ø½ÄÀûÀÎ ¿äûÀÌ ÀÖ´Â °æ¿ì

  • ±âŸ»çÇ×

    °¢ ¼­ºñ½ºÀÇ Çʿ伺¿¡ µû¶ó ¹Ì¸® °øÁöÇÑ °æ¿ì

    ±âŸ ¹ý·ü¿¡ ÀúÃ˵Ǵ Á¤º¸ °ÔÀ縦 ¸ñÀûÀ¸·Î ÇÒ °æ¿ì

    ±âŸ ¿ø¸¸ÇÑ ¿î¿µÀ» À§ÇØ ¿î¿µÀÚ°¡ ÇÊ¿äÇÏ´Ù°í ÆǴܵǴ ³»¿ë

  • »ç½Ç °ü°è È®ÀÎ ÈÄ »èÁ¦

    ÀúÀÛ±ÇÀڷκÎÅÍ Çã¶ô¹ÞÁö ¾ÊÀº ³»¿ëÀ» ¹«´Ü °ÔÀç, º¹Á¦, ¹èÆ÷ÇÏ´Â °æ¿ì

    ŸÀÎÀÇ ÃÊ»ó±ÇÀ» ħÇØÇϰųª °³ÀÎÁ¤º¸¸¦ À¯ÃâÇÏ´Â °æ¿ì

    ´ç»ç¿¡ Á¦°øÇÑ ÀÌ¿ëÀÚÀÇ Á¤º¸°¡ ÇãÀ§ÀÎ °æ¿ì (ŸÀÎÀÇ ID, ºñ¹Ð¹øÈ£ µµ¿ë µî)

  • ¡ØÀÌ»óÀÇ ³»¿ëÁß ÀϺΠ»çÇ׿¡ Àû¿ëµÉ °æ¿ì ÀÌ¿ë¾à°ü ¹× °ü·Ã ¹ý·ü¿¡ ÀÇÇØ Á¦À縦 ¹ÞÀ¸½Ç ¼öµµ ÀÖÀ¸¸ç, ¹Î¡¤Çü»ç»ó ó¹úÀ» ¹ÞÀ» ¼öµµ ÀÖ½À´Ï´Ù.

    ¡ØÀ§¿¡ ¸í½ÃµÇÁö ¾ÊÀº ³»¿ëÀÌ´õ¶óµµ ºÒ¹ýÀûÀÎ ³»¿ëÀ¸·Î ÆǴܵǰųª µ¥Àϸ®ÆÊ ¼­ºñ½º¿¡ ¹Ù¶÷Á÷ÇÏÁö ¾Ê´Ù°í ÆǴܵǴ °æ¿ì´Â ¼± Á¶Ä¡ ÀÌÈÄ º» °ü¸® ±âÁØÀ» ¼öÁ¤ °ø½ÃÇÏ°Ú½À´Ï´Ù.

    ¡Ø±âŸ ¹®ÀÇ »çÇ×Àº µ¥Àϸ®ÆÊ ¿î¿µÀÚ¿¡°Ô ¿¬¶ôÁֽʽÿÀ. ¸ÞÀÏ ÁÖ¼Ò´Â dailypharm@dailypharm.comÀÔ´Ï´Ù.

Ãֽżø Âù¼º¼ø ¹Ý´ë¼ø
  • 2005.04.28 00:41:37 ¼öÁ¤ | »èÁ¦

    injectibles

    It is really sad that physicians need to be forced to be compliant with the policy in this way. However, it is not the policy at all. Rather, it is more scientific and evidence-based. IV drugs are required only in those circumstances: 1. There is no oral formulations available 2. Patients cannot eat food (GI problems, some neurological diseases etc) 3. When rapid onset of action of the drug is required (seizure, severe infection etc) In other cases, oral administration has at least comparable efficacy to IV (even in infections shown by many clinical studies) and has some advantages: 1. Avoid high peaks that are associated with more side effects 2. Avoid injection-related complications including infection and inflammation 3. Cheap In addition, most of the patients who need IV administration are not (should not be treated as) an outpatient. Therefore, the IV drug use by outpatient clinic cannot be justified in msot cases. In addition, the argument by KMA is not based on the scientific evidence, which they have to pursue. Their blame on the culture in Korea is also unacceptable given that physicians rather than the patients are an expert in medicine. If a patient asks an IV, an informed and learned physician should be able to persuade those patients not to take IV by explaining disadvantages of the IV drugs. Even a patient who has been treated with self-medications purchased from a pharmacy can be safely and effectively treated with oral medications if the patient can be treated as an outpatient as shown in the medical literature. Therefore, the argument seems to be based on emotion not on science and evidence. If they do not practice evidence-based medicine, then the government forces them to do so.

    ´ñ±Û 3 0 0
    • sibalnoma40515
      2005.04.28 13:05:31 ¼öÁ¤ | »èÁ¦
      jos ga tn nom a
    • ÀÌ·¸°Ô40493
      2005.04.28 09:52:13 ¼öÁ¤ | »èÁ¦
      ¾Ë ¾Æ´Â Àΰ£µéÀÌ ¿Ö±×·¡?
    • °¡¹æ²ö40486
      2005.04.28 09:23:39 ¼öÁ¤ | »èÁ¦
      ¿Ü±¹°¡¼­ 'Àå»ç'ÇϼÅ
    µî·Ï
¾à±¹ ÀÏ¹Ý¾à ¸ÅÃâ¾× Top 100(09¿ù)
¼øÀ§ »óÇ°¸í Ƚ¼ö ¼ö·® ÆǸűݾ×
1 ŸÀÌ·¹³îÁ¤500mg(10Á¤) 36267 52185 158,442,200¿ø
2 ±î½ºÈ°¸í¼öÅ¥¾× 11585 69363 81,503,501¿ø
3 ÆÇÄÝ¿¡½º³»º¹¾× 9914 72699 62,194,900¿ø
4 ¾ÖÅ©³íÅ©¸² 5288 5586 61,876,700¿ø
5 ÆÇÇǸ°Å¥¾× 8088 72156 57,654,900¿ø
6 ŸÀÌ·¹³îÁ¤500mg(30Á¤) 5291 8653 53,625,551¿ø
7 ³ë½ºÄ«³ª°Ö 20g 2478 2574 53,272,271¿ø
8 ÄÉÅäÅéÇöó½ºÅ¸(40¸Å) 2874 3506 46,063,240¿ø
9 Ź¼¾ ¿¬Áúĸ½¶(10ĸ½¶) 11659 17262 45,322,000¿ø
10 ¾Æ·Î³ª¹Î°ñµåÇÁ¸®¹Ì¾ö(120Á¤) 847 1012 44,268,000¿ø
11 º¥Æ÷º§S¿¡½ºÁ¤ 726 1257 44,132,300¿ø
12 ºñÆÇÅÙ¿¬°í 30g 3300 6100 40,652,800¿ø
13 ÄÝ´ë¿ø ÄÚÇÁÅ¥½Ã·´ 7749 10227 38,452,700¿ø
14 ÀÌ°¡Åº¿¡ÇÁĸ½¶(60ĸ½¶*3) 1225 1630 36,811,500¿ø
15 ÀÕÄ¡ÆäÀ̽ºÆ®Ä¡¾à 120g 2554 3447 36,402,400¿ø
16 ÅÙÅÙÃòÁ¤(10Á¤) 11482 18964 34,913,801¿ø
17 º£³ªÄ¡¿À¿¡ÇÁ¾× 75ml 7316 37206 33,287,800¿ø
18 ÈĽõò¿¬°í 10g 4120 4453 32,997,700¿ø
19 ¾ÖÅ©¸°°Ö 2653 2737 32,556,944¿ø
20 ŸÀÌ·¹³î8½Ã°£À̾˼­¹æÁ¤ 7375 11127 31,727,880¿ø
21 ÅÙÅÙÃòÁ¤(120Á¤) 1218 3913 31,457,100¿ø
22 °Ôº¸¸°Á¤ 5737 9683 31,242,800¿ø
23 ¸á¶óÅä´×Å©¸² 1435 1489 30,616,200¿ø
24 ±¤µ¿°æ¿Á°í 256 8081 30,550,400¿ø
25 µÑÄÚ¶ô½º-¿¡½ºÀå¿ëÁ¤(40Á¤) 1770 4237 29,459,700¿ø
26 ¸¶µ¥Ä«¼ÖÄɾ°í 10g 3912 4268 28,976,450¿ø
27 ÀÌÁö¿£6À̺ê(30ĸ½¶) 3231 3924 27,802,250¿ø
28 ÈĽõò¿¬°í 5g 4780 5065 27,027,501¿ø
29 µ¿¾ÆD-ÆÇÅ׳°í 2376 2542 25,161,000¿ø
30 ¹éÃʽ÷´Ç÷¯½º 3667 4551 24,704,400¿ø
31 ±¤µ¿¿ìȲû½É¿øÇöŹ¾×50ml(õ¿¬»çÇâ) 896 1857 24,694,602¿ø
32 ÄÉÅäÅéÇöó½ºÅ¸(34¸Å) 1708 2510 24,577,000¿ø
33 ¸¶µ¥Ä«¼Ö°Ö 2197 2790 24,211,400¿ø
34 ¸Ó½Ã·ÐÁ¤ 2165 2582 24,012,800¿ø
35 ¾Æ·º½º´ëÇü 3058 7412 23,625,851¿ø
36 ÇÁ·»Áî¾ÆÀ̵å·ÓÁ¡¾È¾×ÄðÇÏÀÌ ¾÷14ml 3620 4016 23,397,550¿ø
37 ÀÕÄ¡ÆäÀ̽ºÆ®ÇÇÅæÄ¡µå 150g 1387 1697 23,152,503¿ø
38 ¿ÀÅ¥½Ã½ºÁ¡¾È¾×0.5ml*60°³ 1205 1443 22,391,550¿ø
39 Å׶óÇ÷ç Äݵå&ÄÚÇÁ ³ªÀÌÆ® 1629 1937 22,248,080¿ø
40 ¸ðµåÄÝ¿¡½º 5409 7872 22,203,000¿ø
41 ÄÉÆèÇöó½ºÅ¸ 3505 8343 21,945,802¿ø
42 ±¤µ¿¿ìȲû½É¿øÇöŹ¾×50ml(¿µ¹¦Çâ) 1274 2641 21,462,400¿ø
43 ºñ¸Æ½º¸ÞŸºñ 357 633 21,196,300¿ø
44 ¾Æ·Î³ª¹Î°ñµå(100Á¤) 640 1080 21,188,900¿ø
45 Áö¸£ÅØÁ¤ 3327 4498 20,999,700¿ø
46 Àλ絹Ç÷¯½º(100Á¤) 614 1430 20,947,900¿ø
47 ÇÁ·»Áî¾ÆÀ̵å·ÓÁ¡¾È¾×Äð ¾÷ 3303 3556 20,688,723¿ø
48 ½º¿þÆ®·ÑÆеå¾× 1084 3267 20,099,800¿ø
49 ³ë½ºÄ«³ª°Ö 10g 1580 1610 20,095,600¿ø
50 ºñ¸Æ½ºÁ¦Æ®Á¤ 209 387 19,985,200¿ø
51 Åõ¿¢½ººñÆ®¸®ÇÃÁ¤ 275 510 19,912,100¿ø
52 ¸¶µ¥Ä«¼ÖÄɾ°í 6g 3834 4092 19,782,800¿ø
53 ¶ó¶ó¿Ã¶ó¾× 20mL 1588 6259 19,414,100¿ø
54 Ź¼¾·¹À̵ð 4067 5178 19,405,400¿ø
55 ÄÝ´ë¿øÄݵåÅ¥½Ã·´ 3970 5195 19,127,070¿ø
56 Ź¼¾ ¿¬Áúĸ½¶(30ĸ½¶) 2168 3027 19,053,200¿ø
57 ÀÌÁö¿£6À̺꿬Áúĸ½¶ 5417 7160 19,048,900¿ø
58 ±¤µ¿¿ìȲû½É¿øȯ(»çÇâ) 222 1341 18,974,500¿ø
59 ¸¶±×ºñ¸Æ½º¿¬Áúĸ½¶ 361 603 18,246,612¿ø
60 ¿ëÇ¥¿ìȲû½É¿ø¾× 50ml 1444 3623 17,955,500¿ø
61 Ŭ¸®¾îƾ 1437 1494 17,754,094¿ø
62 ¼¾½Ã¾ÆÁ¤(120Á¤) 314 792 17,663,300¿ø
63 èÇÁ½Ã·´ 2945 3502 17,634,610¿ø
64 ¸¶±×ºñ½ºÇǵå¾× 1606 8387 17,470,601¿ø
65 ¼¾½Ã¾Æ(180Á¤) 225 593 17,302,000¿ø
66 ´ÏÄÚ·¹Æ®²­ 2mg (Äð¹ÎÆ®Çâ) 737 2080 17,021,800¿ø
67 ´ºº£ÀÎ¾× 662 7559 16,993,004¿ø
68 ÇÁ·»Áî¾ÆÀ̵å·ÓÁ¡¾È¾×¼ø ¾÷ 2585 2880 16,815,140¿ø
69 ¸ñ¾Ø½ºÇÁ·¹ÀÌ 1622 1704 16,799,900¿ø
70 À¯ÇѺñŸ¹ÎCÁ¤1000mg 871 3880 15,894,201¿ø
71 ¾Æ·º½ºÁßÇü 2949 4927 15,698,553¿ø
72 ŸÀÌ·¹³îÄݵ忡½ºÁ¤ 3032 4712 15,579,400¿ø
73 ¸á¸®¾ÈÁ¤ 1456 1777 15,457,000¿ø
74 ¸Æ½ÃºÎÅ°Áî½Ã·´ 2835 3504 15,351,200¿ø
75 Àλ絹Ç÷¯½º(270Á¤) 196 1007 15,329,700¿ø
76 ¼¼ºñŸºñ°Ö 1188 1258 15,317,600¿ø
77 ÀÌÁö¿£6ÇÁ·Î ¿¬Áúĸ½¶(30ĸ½¶) 1713 1905 15,230,000¿ø
78 ´ë¿õ¿ì·ç»ç¿¬Áúĸ½¶(120ĸ½¶) 384 398 15,172,400¿ø
79 Å׶óÇÃ·ç ³ªÀÌƮŸÀÓ 1535 1827 15,037,000¿ø
80 À¯ÇÑ ÀÌÁöÄÉ¾î ³×À϶óÄ« 510 841 15,023,000¿ø
81 ºñ¸Æ½º¸ÞŸÁ¤ 285 536 14,982,900¿ø
82 ÄÚ¾ØÄ𠳪Àß½ºÇÁ·¹ÀÌ 1273 1481 14,584,401¿ø
83 ¸ðµåÄÚÇÁ¿¡½º 4092 5501 14,552,800¿ø
84 ¸ÞÀÌŲťÀå¿ëÁ¤(40Á¤) 1260 2116 14,484,300¿ø
85 µ¿¼ºÁ¤·Îȯ¿¡ÇÁÁ¤ 2266 3059 14,351,000¿ø
86 ½ºÆ®·¾½ÇÆ®·ÎÅ°(Çã´Ï&·¹¸ó) 2106 3174 14,336,240¿ø
87 ½á¹öÄð¾× 2767 2982 14,313,420¿ø
88 ¸¶±×ºñ½ºÇÇµå ´õºí¾×¼Ç 959 4470 14,268,799¿ø
89 Àλ絹(100Á¤) 459 674 14,054,100¿ø
90 ¼ÒÇÏÀÚÀÓÇ÷¯½ºÁ¤ 3809 4516 13,834,944¿ø
91 ¿ÀÆ®¸®ºó¸àÅç0.1%ºÐ¹«Á¦ 1049 1398 13,697,899¿ø
92 Á¶¾ÆÆË(10¸Å) 1697 2876 13,697,200¿ø
93 ÈѽºÅ»Ç÷¯½º 3069 4705 13,566,900¿ø
94 °ÖÆ÷½º¿¤(6Æ÷) 1711 2313 13,500,000¿ø
95 ¼¾½ºµ¥ÀÌÁ¤ 1355 1799 13,487,200¿ø
96 ÀÌÁö¿£6ÇÁ·Î¿¬Áú(10ĸ½¶) 3699 5247 13,470,778¿ø
97 ¾ÆÀ̹̻ê 227 16888 13,350,000¿ø
98 ±Â¸ð´×¿¡½º°ú¸³ 1390 2805 13,330,802¿ø
99 Æǽõôĸ½¶(270ĸ½¶) 126 402 13,259,000¿ø
100 ¾ÈƼǪ¶ó¹Î ´õºíÆÄ¿ö ´ëÇü 1694 3706 13,242,025¿ø
Àüüº¸±â



ÀÎÅͳݽŹ®µî·Ï¹øÈ£: ¼­¿ï,¾Æ52715 | µî·ÏÀÏÀÚ 2019.11.20 | ¹ßÇàÀÏÀÚ 2019.11.20 | ¹ßÇàÀÎ : ÀÌÁ¤¼® | ÆíÁýÀÎ : °¡ÀÎÈ£
¹ßÇàÁÖ¼Ò: ¼­¿ï½Ã ¼ÛÆı¸ ¹ý¿ø·Î 128 ¹®Á¤ SK V1 GL ¸ÞÆ®·Î½ÃƼ Aµ¿ 401È£
ÀüÈ­ : 02-3473-0833 |Æѽº : 02-3474-0169 | û¼Ò³âº¸È£Á¤Ã¥(Ã¥ÀÓÀÚ °­½Å±¹)
Contact dailypharm@dailypharm.com for more information
µ¥Àϸ®ÆÊÀÇ ¸ðµç ÄÜÅÙÃ÷(±â»ç)¸¦ ¹«´Ü »ç¿ëÇÏ´Â °ÍÀº ÀúÀ۱ǹý¿¡ ÀúÃ˵Ǹç, ¹ýÀû Á¦À縦 ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù.